Kilitch Drugs (India) Ltd. (KILITCH) Drugs (India) Share Price Near 52-Week High as Stock Trades at Rs 264
- September 24, 2026
- Posted by: Chaitanya Auti
- Category: News
Kilitch Drugs (India) Share Price is trading at Rs 264, up Rs 2.70 or 1.03%, and remains close to its 52-week high as of 07 October 2026 at 9:22 AM IST. The company’s market capitalisation stands at Rs 816.35 crore, which places the move in a clear market-cap context for investors tracking Kilitch Drugs (India) Stock News and Kilitch Drugs (India) Share Price Today.
The latest Univest data confirms the price event but does not establish a company-specific catalyst. What it does show is a stock that has moved to Rs 264 from a previous close of Rs 261.30, with the day’s range stretching from Rs 261.45 to Rs 267.90. For readers searching Kilitch Drugs (India) Share Price, the key point is simple: the share is trading near a 52-week high, and the market is now seeing whether the current level can hold while broader Kilitch Drugs (India) Stock News stays in focus.
Kilitch Drugs (India) Share Price Today: Price Action Analysis
This Kilitch Drugs (India) Share Price Today update matters because it combines a near 52-week-high event with valuation and financial data that help explain why the stock keeps drawing attention on Univest and in Indian Stock Market screens.
| Metric | Value |
|---|---|
| Current Price | Rs 264 |
| Previous Close | Rs 261.3 |
| Today's Move | +Rs 2.7 (+1.03%) |
| Open | Rs 261.45 |
| High | Rs 267.9 |
| Low | Rs 261.45 |
| Market Capitalisation | Rs 816.35 crore |
Kilitch Drugs (India) Ltd. (KILITCH) traded at Rs 264 versus the previous close of Rs 261.3, a rise of 1.03%. The stock opened at Rs 261.45, reached a high of Rs 267.9 and touched a low of Rs 261.45.
Kilitch Drugs (India) Share Price Today opened at Rs 261.45, matched the day’s low at the same level, and moved up to a high of Rs 267.90 before trading at Rs 264. That left the stock Rs 2.70 above the previous close of Rs 261.30. In percentage terms, the change was 1.03%, which keeps the name within sight of its 52-week high and reinforces the event flagged in Univest market screens.
For Kilitch Drugs (India) Share News, the important observation is that the share price stayed above the opening level and traded near the upper end of the day’s range. The latest Kilitch Drugs (India) Share Price Live data therefore shows a measured rise rather than a large swing. Since the latest Univest figures do not establish a company-specific catalyst, the focus stays on the verified price move itself and on how close the stock remains to its yearly high.
Seen through the lens of Kilitch Drugs (India) Stock Performance, the move also keeps the stock on watchlists for 52 Week High Stocks and Stocks in News. The next section looks at Kilitch Drugs (India) Fundamental Analysis to place that price action alongside earnings and valuation measures.
Kilitch Drugs (India) Ltd. (KILITCH) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 816.35 crore |
| P/E Ratio | 30.4x |
| P/B Ratio | 3.25x |
| ROE | 12.26% |
| ROCE | 14.5% |
| EPS | Rs 8.6 |
| Book Value Per Share | Rs 80.45 |
| Dividend Yield | 0% |
Kilitch Drugs (India) Ltd. (KILITCH) fundamental metrics show P/E 30.4x, P/B 3.25x, ROE 12.26%, ROCE 14.5%. These figures provide context only and are not a buy or sell signal.
Kilitch Drugs (India) Ltd. has a market capitalisation of Rs 816.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.4x, P/B at 3.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.26% and ROCE of 14.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 8.6, book value per share of Rs 80.45, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.27x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.4x |
| Benchmark Median P/E | 28.27x |
| Benchmark Average P/E | 41.2x |
| Benchmark P/E Range | 0x to 695.67x |
| Company P/B Ratio | 3.25x |
| Benchmark Median P/B | 2.86x |
| Company ROE | 12.26% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 14.5% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 816.35 crore |
| Benchmark Median Market Cap | Rs 806.68 crore |
Kilitch Drugs (India) Ltd. (KILITCH) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kilitch Drugs (India) Ltd. (KILITCH) has a P/E ratio of 30.4x, which is above the benchmark median of 28.27x, a difference of +7.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kilitch Drugs (India) Ltd. (KILITCH) has a ROE of 12.26%, which is above the benchmark median of 11.61%, a difference of +5.6%. Kilitch Drugs (India) Ltd. (KILITCH) has a ROCE of 14.5%, which is above the benchmark median of 13.46%, a difference of +7.73%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| HEXAGON NUTRITION LIMITED | HEXAGON | 849.98 | 22.84 | 3.57 | 14.11 | 17.37 |
| Amanta Healthcare Ltd. | AMANTA | 763.39 | 52.02 | 3.42 | 9.4 | 11.23 |
| Shree Ganesh Remedies Ltd. | SGRL | 875.4 | 59.66 | 5.61 | 11.53 | 14.63 |
| Anuh Pharma Ltd. | ANUHPHR | 879.16 | 19.9 | 2.42 | 12.1 | 16.02 |
| Zim Laboratories Ltd. | ZIMLAB | 731.1 | 201.07 | 2.56 | 2.14 | 5.47 |
Kilitch Drugs (India) Ltd. (KILITCH) has a P/E ratio of 30.4x compared with the displayed peer median of 52.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.26% compares with a peer median of 11.53% across the companies shown in the table. ROCE stood at 14.5% versus the displayed peer median of 14.63%, providing a capital-efficiency comparison. Kilitch Drugs (India) Ltd. (KILITCH) has a market capitalisation of Rs 816.35 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Kilitch Drugs (India)
- Kilitch Drugs (India) Share Price is Rs 264, up 1.03% from the previous close of Rs 261.30.
- The stock is trading near its 52-week high, which keeps Kilitch Drugs (India) Share Price Today on market screens.
- Market capitalisation is Rs 816.35 crore, close to the same-industry median of Rs 806.68 crore.
- P/E at 30.4 and P/B at 3.25 place Kilitch Drugs (India) Share Price inside the healthcare benchmark range.
- ROE of 12.26% and ROCE of 14.5% are above the same-industry medians in the sector snapshot.
About Kilitch Drugs (India)
Kilitch Drugs (India) Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. Kilitch Drugs (India) Share Price today is being tracked by investors who follow listed healthcare names on NSE and BSE. The company’s latest quarter revenue was Rs 44.88 crore for Jun 2026, and its current market capitalisation is Rs 816.35 crore. These company facts help frame Kilitch Drugs (India) Stock News in the context of a listed pharma business rather than a broad market theme.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Kilitch Drugs (India) Share Price today?
Ans. Kilitch Drugs (India) Share Price is Rs 264, up Rs 2.70 or 1.03% from the previous close of Rs 261.30. The stock is also trading near its 52-week high, which keeps it on market watchlists.
Why is Kilitch Drugs (India) Share Price in focus today?
Ans. Kilitch Drugs (India) Share Price is in focus because it is trading near its 52-week high and above the previous close. The latest Univest figures confirm the price event, but do not establish a company-specific catalyst.
What was Kilitch Drugs (India) Share Price range today?
Ans. Kilitch Drugs (India) Share Price moved between Rs 261.45 and Rs 267.90 during the day. It opened at Rs 261.45 and was last seen at Rs 264, staying close to the upper part of that range.
What is the market capitalisation of Kilitch Drugs (India)?
Ans. Kilitch Drugs (India) has a market capitalisation of Rs 816.35 crore. That figure sits close to the same-industry median of Rs 806.68 crore in the Healthcare and Pharmaceuticals & Drugs universe.
How does Kilitch Drugs (India) compare on valuation?
Ans. Kilitch Drugs (India) Share Price is backed by a P/E of 30.4 and a P/B of 3.25. In the same-industry snapshot, both are above the median but below the average, which gives useful valuation context.
What do Kilitch Drugs (India) EPS and book value show?
Ans. Kilitch Drugs (India) reports EPS of Rs 8.6 and book value of Rs 80.45 per share. EPS reflects earnings per share, while book value shows accounting net worth per share behind Kilitch Drugs (India) Share Price.
Does Kilitch Drugs (India) pay a dividend?
Ans. Kilitch Drugs (India) has a dividend yield of 0. That means no dividend yield is reflected in the current update, so Kilitch Drugs (India) Share Price is being read mainly through price, valuation and profitability ratios.
What should investors monitor in Kilitch Drugs (India) Stock News?
Ans. Investors can track Kilitch Drugs (India) Share Price Today, the 52-week high position, P/E, P/B, ROE, ROCE and the latest revenue figure of Rs 44.88 crore for Jun 2026. These metrics frame the stock’s current market setup.
Track Kilitch Drugs (India) Share Price on Univest
Use Kilitch Drugs (India) Ltd. (KILITCH) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Kilitch Drugs (India) Share Price on Univest for live price updates, 52-week levels, company fundamentals, peer comparisons and market insights. Univest also helps readers follow Kilitch Drugs (India) Share Price Today alongside its valuation ratios, revenue trend and broader healthcare sector context.